Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of cariprazine hydrochloride capsules versus aripiprazole in adults with acute exacerbation of schizophrenia
CTR20253439Phase 3Active
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Jiangsu Nhwa Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20253439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253439.